- The National
Pharmaceutical Pricing Authority of India aims to fix and control the prices of
bulk drugs and formulations.
- Government fixes the ceiling
price for 54 essential drugs and 11 retail formulations recently to make
medicines easily accessible.
- Drug price has been slashed by
over 55% for essential medicines and anticancer drug
Trastuzumab has been made cheaper by 25%.
manufacturers, distributors and retailers should execute the revised ceiling
Pharmaceutical Pricing Authority (NPPA)
by the Government of India has reduced
the prices of 54 essential drugs by over 55%.
The decision was
mainly made to control the drug price
make them easily affordable for the treatment of cancer
, diabetes and other critical diseases.
ceiling prices of 54 drugs of schedule I under Drugs Price Control Order 2016
and drug price of 11 retail formulations under Drug Price Control Order 2013 in
related notification was fixed by NPPA on May 9th
, 2016. Drug manufacturers, distributors and retailers were asked to
execute the government imposed price as quickly as possible.
‘The Government of India slashes the ceiling price of essential drugs by 55% to make medicines affordable.’
Pharmaceutical Pricing Authority
of India has established the National Pharmaceutical Pricing Authority under
DPCO 1995 to fix, revise and control the prices of bulk drugs and
. It also carries out various other functions related to drug
pricing and help in monitoring the availability of drugs, identifies shortage
and takes necessary actions respectively.
The NPPA Organization is headed by the Chairman Bhupinder Singh and consists of
Secretary members who administer and monitor the overcharging prices of the
drugs. Followed by the Advisors who make the essential policies that are
required and handle the legal issues related to the price control.
of Drugs Goes Down By 55%
Ministry of India is constantly taking measures to reduce the drug price and
has also increased the initial number of 684 drugs as to 875 drugs which need
price control. NPPA has so far reduced the prices of about 280 drugs
And the prices of 54 drugs that have been reduced by NPPA recently also come
under the National List of Essential Medicines, 2015.
The prices of
drugs that have been lowered are mainly drugs that are being used in the treatment
of cancer, diabetes and hypertension. Medicines like Trastuzumab
is used for breast cancer
has been made cheaper by 25%. The price of beta blockers like propranolol, metoprolol and ACE inhibitors like ramipril
used in the treatment of high blood pressure
has been reduced.
Some of the
prices of retail formulations used in thetreatment of diabetes
such as combinations of glimepiride with metformin, teneligliptin with metformin
has also been decreased
by the pricing authority.
The prices fixed
by NPPA was made by focusing primarily on the retail price of the drug that is
being sold in the market.
This reduction will make the drugs more affordable for the patients and consumers.